Polar Asset Management Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Polar Asset Management Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-70,000	Closed	-$7.01M	–	851
2025 Q3	$7.01M	Buy	+70,000	New	+$6.3M	0.08%	193
2025 Q2	–	Sell	-122,000	Closed	-$9.89M	–	721
2025 Q1	$9.89M	Sell	122,000 -228,000	-65%	-$20.4M	0.23%	111
2024 Q4	$31.5M	Buy	350,000 +250,000	+250%	+$24.2M	0.37%	56
2024 Q3	$9.88M	Buy	+100,000	New	+$9.83M	0.21%	119
2015 Q3	–	Sell	-150,000	Closed	-$12.6M	–	256
2015 Q2	$12.6M	Buy	+150,000	New	+$11.7M	0.55%	49

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Polar Asset Management Partners's XBI Position: Q2 2024 in Review

Polar Asset Management Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 74,500 shares — an estimated $7.07M sold.

Polar Asset Management Partners first reported a position in XBI in Q1 2016 and held it in 3 quarters. The position peaked at $18.7M in Q4 2023. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Polar Asset Management Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Polar Asset Management Partners sold 74,500 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $7.07M.
Polar Asset Management Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2016 and held it in 3 quarters.
Polar Asset Management Partners's State Street SPDR S&P Biotech ETF position peaked at $18.7M in Q4 2023.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Polar Asset Management Partners's 13F filing for Q2 2024, filed 14 Aug 2024.